Search Results - John Sapp

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Unmasking culprits: novel analysis identifies complement factors as potential therapeutic targets to mitigate inflammation during children's heart surgery by Joel Bierer, Roger Stanzel, Mark Henderson, John Sapp, Pantelis Andreou, Jean S. Marshall, David Horne

    Published in European Journal of Medical Research (2024-12-01)
    Get full text
    Article


  2. 2

    High-exchange ULTrafiltration to enhance recovery after paediatric cardiac surgery (ULTRA): study protocol for a Canadian double-blinded randomised controlled trial by Pantelis Andreou, John Sapp, Mark Henderson, David Horne, Joel Bierer, Roger Stanzel, Kristina Krmpotic, Jean S. Marshall

    Published in BMJ Open (2024-08-01)
    Get full text
    Article


  3. 3

    Complement activation by the artificial surface of cardiopulmonary bypass is a persistent clinical problem by Joel David Bierer, Roger Stanzel, Mark Henderson, Tony El-Rabahi, John Sapp, Pantelis Andreou, Jean S. Marshall, David Conrad, David Horne

    Published in Scientific Reports (2025-07-01)
    Get full text
    Article


  4. 4

    Haptoglobin phenotype and intensive glycemic control for coronary artery disease risk reduction in people with type two diabetes: The Veterans Affairs Diabetes Trial by Leah E Cahill, Rachel A Warren, Gideon D Bahn, Allie S Carew, Andrew P Levy, John Sapp, Eric B Rimm, Peter Reaven

    Published in American Journal of Preventive Cardiology (2024-06-01)
    Get full text
    Article


  5. 5

    Intensive lifestyle intervention in type 2 diabetes and risk of incident coronary artery disease for the common haptoglobin phenotypes: the Look AHEAD study by Rachel A. Warren, Michael P. Bancks, Allie S. Carew, Andrew P. Levy, John Sapp, Judy Bahnson, Cora E. Lewis, Eric B. Rimm, Mark A. Espeland, Leah E. Cahill

    Published in Cardiovascular Diabetology (2024-02-01)
    Get full text
    Article


  6. 6

    Relationship Between Time‐Varying Achieved High‐Density Lipoprotein Cholesterol and Risk of Coronary Events Depends on Haptoglobin Phenotype Within the ACCORD Lipid Study by Rachel A. Warren, Allie S. Carew, Pantelis Andreou, Andrew P. Levy, John Sapp, Orit Lache, Henry N. Ginsberg, Eric B. Rimm, Christine Herman, Susan Kirkland, Leah E. Cahill

    Get full text
    Article


  7. 7

    Differential effects of dual antiplatelet and dual antithrombotic therapy on hemostasis in chronic coronary syndrome patients: the DEFINE CCS study by Tony Haddad, Osama Elkhateeb, Lawrence Title, Ata Quraishi, Wan Cheol Kim, Ali Hillani, Scott Grandy, Stefan S. Heinze, Finn Eichhorn, Hannah Harquail, John Sapp, William Parker, Shamir R. Mehta, Robert F. Storey, Wael Sumaya

    Published in Platelets (2025-12-01)
    Get full text
    Article


  8. 8

    Relationship between time-varying achieved HbA1c and risk of coronary artery disease events among common haptoglobin phenotype groups with type 2 diabetes: the ADVANCE study by Giuseppe Mancia, Mark Woodward, John Chalmers, Neil Poulter, Eric Rimm, Elizabeth Selvin, Michel Marre, Michelle Samuel, Stephen Harrap, Katie Harris, John Sapp, Leah E Cahill, Rachel A Warren, Samantha K Lavallée, Andrew P Levy, Allie S Carew

    Published in BMJ Open Diabetes Research & Care (2025-05-01)
    Get full text
    Article


Search Tools: